In addition, recent studies have also implicated aberrant activity of hematopoietic transcription factors and their co-activators, such as MYB and CBP/P300, in recruitment of the basal transcriptional apparatus in AML cells8,11,12. This evidence concerns the gene EP300 and acute myeloid leukemia.